Keywords

Bone cancer

Breast Cancer

General Oncology

Gynecological Cancers

Head and neck cancer

Lung Cancer

Radiation Oncology

Closed Reduction and transcutaneous promise comfortable in Non-Pathologic Fractures in medicine Patients

Correspondence to Author: William Stolarek, 

University in Madison, Wisconsin, US

Abstract:

Introduction: The incidence of hip fractures in patients with a history of cancer is expected to extend, whether or not the fracture is pathologic or not. This study wanted to answer 2 call points: (1) what’s the acceptable imaging modality to see if the fracture is pathologic? (2) Is Osteosynthesis (OS) associate degree applicable technique within the management of limb neck fractures in patients with a history of cancer?

Materials and Methods: we tend to did a retrospective review of patients presenting with limb neck fractures that underwent OS or Hemiarthroplasty (HA) at a single medical specialty referral center. 127 patients were known, 109 underwent HA and eighteen underwent OS. Comparison of the imaging to the microscopic anatomy analysis was performed to see the accuracy, sensitivity, specificity, Positive prognostic price (PPV), and Negative prognostic price (NPV) of the various imaging modalities.

Results: Analysis of picture taking imaging incontestable the addition of advanced imaging improved the accuracy, sensitivity, specificity, PPV, and NPV compared to radiographs alone. each angular distance and OS offered sturdy rehabilitative options.

Discussion and Conclusion: Radiographs while not advanced imaging for comparison are incorrect twenty sixth of the time; advanced imaging improves the accuracy. Osteosynthesis may be a sturdy rehabilitative possibility in patients with a history of cancer while not associate degree underlying pathologic fracture.

Citation:

William Stolarek. Closed Reduction and transcutaneous promise comfortable in Non-Pathologic Fractures in medicine Patients. World Journal of Medical Oncology 2020.

Journal Info

  • Journal Name: World Journal of Medical Oncology
  • Impact Factor: 2.709**
  • ISSN: 2766-6077
  • DOI: 10.52338/wjoncgy
  • Short Name: WJMOY
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days

INDEXING

  • Crossref indexed journal impact factor of 2.980**
  • Publons indexed journal impact factor of 3.90**
  • Pubmed-indexed journal impact factor of 5.2**
  • International Scientific Indexing (ISI)-indexed journal impact factor of 2.980**
  • Eurasian Scientific Journal Index (ESJI) index journal impact factor of 2.980**
  • Semantic Scholar indexed journal impact factor of 2.980**
  • Cosmos indexed journal impact factor of 3.981**

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility